Phillips Medisize, a contract development and manufacturing organization serving medical device and pharma OEMs acquired by Molex in 2016, announced today that it has completed the acquisition of Vectura Group Ltd. from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International Inc. The acquisition adds proprietary technology and combination product development expertise in medical inhalers to the Phillips Medisize portfolio.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,